Cosmetic and dermatological light protection formulations

ABSTRACT

Light protective cosmetic or dermatological preparation, characterized in that it comprises (a) PEG-30 dipolyhydroxystearate, (b) at least one ester of cinnamic acid, (c) at least one dibenzoylmethane derivative and (d) at least 1.5% by weight of titanium dioxide particles (based on the total weight of the preparation).

The present invention relates to cosmetic and dermatological light protection preparations, in particular it relates to cosmetic and dermatological formulations with increased UV-A protection performance.

The harmful effect of the ultraviolet part of solar radiation on the skin is generally known. Depending on their particular wavelength, the rays have different effects on the skin as an organ:

The so-called UV-C radiation with a wavelength between 100 and 280 nm is absorbed by the ozone layer in the Earth's atmosphere and accordingly is not found in the solar spectrum. It is therefore of no physiological importance during sunbathing.

The so-called UV-B region is between 290 nm and 320 nm. UV-B rays are essentially responsible for the long-lasting tanning of the skin, but can at the same time cause an erythema, simple sunburn or even burns of greater or lesser severity. Chronic photodamage, photodermatoses and Herpes solaris can also be caused by UV-B radiation.

It has for a long time been incorrectly assumed that long-wave UV-A radiation with a wavelength between 320 nm and 400 nm only has a negligible biological effect and that, correspondingly, the UV-B rays are responsible for most photodamage to the human skin. However, in the meantime, numerous studies have demonstrated that UV-A radiation is much more hazardous than UV-B radiation with regard to the triggering of photodynamic, specifically phototoxic reactions and chronic changes in the skin. The harmful influence of UV-B radiation can also be further intensified by UV-A radiation.

Thus, it has, inter alia, been found that even UV-A radiation suffices under very normal everyday conditions to harm, within a short time, the collagen and elastin fibres which are of essential importance for the structure and strength of the skin. The consequences are chronic photo-induced changes in the skin—the skin “ages” prematurely. The clinical appearance of skin aged by light includes, for example, wrinkles and lines, and also an irregular, furrowed relief. In addition, the areas affected by photo-induced skin ageing can have irregular pigmentation. The formation of brown spots, keratoses and even carcinomas or malignant melanomas is also possible. Skin aged prematurely by everyday UV exposure is, moreover, characterized by lower activity of the Langerhans cells and slight, chronic inflammation.

Approximately 90% of the ultraviolet radiation which reaches the Earth consists of UV-A rays. While UV-B radiation varies widely depending on numerous factors (e.g. time of year and time of day or degree of latitude), UV-A radiation remains relatively constant day to day irrespective of the time of year and time of day or geographical factors. At the same time, the majority of UV-A radiation penetrates into the living epidermis, while approximately 70% of UV-B rays are retained by the horny layer.

The relatively recent findings concerning the effect of UV-A rays on the skin have led to increased attention now being devoted to protective measures for this ray range. In practice, no sunscreen product is complete any more without an effective UV-A filter effect, and pure UV-B filter preparations are rare.

When applying a sunscreen to the skin, the ultraviolet rays can be weakened through two effects: firstly, by reflection and scattering of the rays at the surface of pulverulent solids (physical light protection) and, secondly, by absorption on chemical substances (chemical light protection). Depending on which wavelength region is absorbed, a distinction is made between UV-B filters (absorption range 280 to 320 nm), UV-A filters (absorption range 320 to 400 nm) and broadband filters (absorption range 290 to about 380 nm).

To protect against UV-B radiation, numerous compounds are known, the absorption maximum of which should be around 308 nm as far as possible since this is the highest erythema effectiveness of solar radiation. Typical UV-B filters are, for example, derivatives of 3-benzylidenecamphor, of 4-aminobenzoic acid, of cinnamic acid, of salicylic acid, of benzophenone, and also of 2-phenylbenzimidazole.

Some compounds are also known for protecting against UV-A radiation, such as, in particular, dibenzoylmethane derivatives. However, dibenzoylmethane derivatives are generally not photostable, as a result of which cosmetic or dermatological preparations with a content of this substance should also comprise certain UV stabilizers.

Besides the pure UV-A or UV-B filters, there are substances which cover both regions. This group of broadband filters includes, for example, asymmetrically substituted s-triazine compounds, such as, for example, 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: BisEthylhexyloxyphenol Methoxyphenyl Triazine), certain benzophenones, such as, for example, 2-hydroxy-4-methoxybenzophenone (INCI: Benzophenone 3) or 2,2′-methylenebis(6-(2H-benzotriazole-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (INCI: Methylene Bis-Benzotriazolyl Tetramethylenebutylphenol).

In general, the light absorption behaviour of light protection filter substances is very well known and documented, especially as there are positive lists for the use of such substances in most industrialized countries, which impose very strict standards on the documentation. Since, in order to characterize a filter substance, not only is the position of the absorption maximum important, but primarily the absorption range, absorption spectra are recorded for each substance. However, the absorbance values can at best be a guide for the concentration of the substances in the finished formulations since interactions with ingredients of the skin or of the surface of the skin itself may give rise to imponderables. In addition, it is usually difficult to estimate beforehand how uniformly and thickly the filter substance is distributed in and on the horny layer of the skin.

To test the UV-A protection performance, use is usually made of the IPD method (IPD≡immediate pigment darkening). Similarly to the determination of the sun protection factor, this method gives a value which indicates how much longer the skin protected with the light protection composition can be irradiated with UV-A radiation until the pigmentation which occurs is the same as for the unprotected skin.

The use concentration of known light protection filter substances which exhibit a high filter effect particularly also in the UV-A region is, however, often limited—especially in combination with other substances to be dissolved. In order, for example, to be able to use large amounts of oil-soluble UV filter substances, a very large oil phase (>about 35% by weight) would be required. However, the hydrophobic phase of an emulsion—for example of a W/O emulsion—could not be chosen to be arbitrarily large since the size of the phases also decisively influences the stability of an emulsion. If a large oil phase (of more than about 35% by weight) is desired, according to the prior art, stabilizers such as waxes or further emulsifiers have to be used in order to obtain an emulsion with a long-term stability of several years. However, a disadvantage of this procedure is that the emulsions become relatively solid as a result and can no longer be distributed as well—particularly on hairy skin.

A further method known according to the prior art for preparing light protection preparations with very high light protection factors (LPF greater than 25) consists in combining UV filter substances such that the entire amount of UV filter is not in the oil phase of the emulsion, which is of course only possible if water-soluble UV filter substances are also used. A disadvantage of such emulsions which comprise water-soluble UV filter substances is that these are usually only water-resistant to a limited extent.

The water resistance of light protection formulations is, however, attributed particular importance since most sunscreen compositions are applied in the vicinity of water or during sporting activity (sweating). A water-resistant sunscreen composition protects the user not only after bathing, but also protects him against sunburn during bathing. It is a widespread misconception that water offers good or even adequate protection against ultraviolet radiation. Rather, investigations have shown that even 1 m below the surface of the water, the transmittance for UV-B rays is about 50%. It is therefore advisable for those who participate in water sports, who, for example, swim, surf or snorkel, and in particular children, who often play for hours at or in the water, to also protect the skin against overly intense and excessive solar irradiation with a sun product which adheres well and can only be rinsed off with difficulty by (salt) water and perspiration.

For the purposes of optimum water resistance, the omission of water-soluble UV filters would therefore be desirable.

It was therefore an object of the present invention to arrive, in a simple and cost-effective manner, at preparations which achieve high broadband protection performance and at the same time are characterized by good water resistance and good distributability.

It was surprising and unforeseeable by the person skilled in the art that a light protective cosmetic or dermatological preparation, characterized in that it comprises

(a) PEG-30 dipolyhydroxystearate,

(b) at least one ester of cinnamic acid,

(c) at least one dibenzoylmethane derivative and

(d) at least 1.5% by weight of titanium dioxide particles (based on the total weight of the preparation),

would overcome the disadvantages of the prior art.

The preparations according to the invention are entirely satisfactory preparations in every respect which exhibit very good sensory and cosmetic properties, such as, for example, distributability on the skin or the ability to absorb into the skin. They are further characterized by very good light protection effectiveness, an exceptionally high broadband protection performance and by excellent skin compatibility coupled with excellent skin care data.

It is particularly surprising and one of the particular advantages of the present invention that despite a high oil phase fraction of more than 35% by weight (based on the total weight of the preparation), no further emulsifier or coemulsifier is necessary and that in addition the fraction of further stabilizers, such as waxes, can be chosen to be very low (less than 1.5% by weight, ideally less than 1 % by weight). In this way, despite a high oil phase, a flowable formulation (with a viscosity of <10 000 mPa•s—determinable using a Haake viscotester VT-02 at 25° C.) is obtained and thus good distributability and optimum light protection are ensured.

The particularly high broadband protection is achieved through the special combination of UV filters of a filter liquid at room temperature (25° C.) (cinnamic ester), a solid lipophilic filter (dibenzoylmethane derivative) and a pigmentary filter (TiO₂).

The substance combinations according to the invention have a surprising synergistic effect, i.e. have a superadditive effect relative to the individual components, and exhibit a surprisingly high protection performance in the UV-A and UV-B region.

Particularly advantageous preparations for the purposes of the present invention comprise more than 3% by weight, in particular more than 8% by weight—in each case based on the total weight of the preparation—of UV filter substances according to the invention. It is also advantageous according to the invention if titanium dioxide has the highest (weight) fraction in the UV filter combination according to the invention.

PEG-30 dipolyhydroxystearate is sold by Uniquema under the trade name ARLACEL® P135.

Cinnamic esters preferred according to the invention are 2-ethylhexyl 4-methoxycinnamate (INCI: Ethylhexyl Methoxycinnamate) and isopentyl 4-methoxycinnamate (INCI: Isoamyl p-Methoxycinnamate), which can advantageously be used in each case individually or in any combinations with one another.

An advantageous dibenzoylmethane derivative for the purposes of the present invention is in particular 4-(tert-butyl)-4′-methoxydibenzoylmethane (CAS No. 70356-09-1), which is sold by Givaudan under the trade name Parsol® 1789 and by Merck under the trade name Eusolex® 9020. Also advantageous is 2,2′-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol). The dibenzoylmethane derivative or derivatives can be used advantageously in each case individually or in any combinations with one another.

According to the invention, the titanium dioxide particles may advantageously be surface-treated (“coated”), the intention being to form or retain, for example, a hydrophilic, amphiphilic or hydrophobic character. This surface treatment can consist in providing the pigments with a thin hydrophilic and/or hydrophobic inorganic and/or organic coating by methods known per se. For the purposes of the present invention, the various surface coatings may also comprise water.

For the purposes of the present invention, the titanium dioxide particles may also advantageously be used in the form of commercially obtainable oily or aqueous predispersions. Dispersion auxiliaries and/or solubility promoters may advantageously be added to these predispersions.

Titanium dioxide particles and predispersions of titanium dioxide particles which are advantageous according to the invention are obtainable under the following trade names from the companies listed: Trade name Coating Manufacturer MT-100TV Aluminium hydroxide/ Tayca Corporation stearic acid MT-100Z Aluminium hydroxide/ Tayca Corporation stearic acid Eusolex T-2000 Alumina/simethicone Merck KGaA Titanium dioxide T805 Octyltrimethylsilane Degussa (Uvinul TiO₂) Tioveil AQ 10PG Alumina/silica Solaveil/Uniquema

For the purposes of the present invention, the preparations are preferably in the form of W/O emulsions.

The cosmetic or dermatological light protection formulations according to the invention can have the customary composition and be used for cosmetic or dermatological light protection, and also for the treatment, care and cleansing of the skin and/or of the hair and as a make-up product in decorative cosmetics.

Depending on their formulation, cosmetic or topical dermatological compositions for the purposes of the present invention can, for example, be used as skin protection cream, cleansing milk, day or night cream etc. It is optionally possible and advantageous to use the compositions according to the invention as a base for pharmaceutical formulations.

For use, the cosmetic and dermatological preparations are applied to the skin and/or the hair in an adequate amount in the manner customary for cosmetics.

The cosmetic and dermatological preparations according to the invention can comprise cosmetic auxiliaries as are customarily used in such preparations, e.g. preservatives, preservative aids, complexing agents, bactericides, perfumes, substances for preventing or increasing foaming, dyes, pigments which have a colouring action, thickeners, moisturizing and/or humectant substances, fillers which improve the feel on the skin, fats, oils, waxes or other customary constituents of a cosmetic or dermatological formulation, such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.

Advantageous preservatives for the purposes of the present invention are, for example, formaldehyde donors (such as, for example, DMDM hydantoin, which is available, for example, under the trade name Glydant™ from Lonza), iodopropyl butylcarbamates (e.g. those available under the trade names Glycacil-L, Glycacil-S from Lonza, and/or Dekaben LMB from Jan Dekker), parabens (i.e. alkyl p-hydroxybenzoates, such as methyl-, ethyl-, propyl- and/or butylparaben), phenoxyethanol, ethanol, benzoic acid and the like. In addition, the preservative system according to the invention also usually advantageously comprises preservative aids, such as, for example, octoxyglycerol, glycine soya etc.

Advantageous complexing agents for the purposes of the present invention are, for example, EDTA, [S,S]-ethylenediamine disuccinate (EDDS), which is available, for example, under the trade name Octaquest from Octel, pentasodium ethylenediamine tetramethylenephosphonate, which is available, for example, under the trade name Dequest 2046 from Monsanto and/or iminodisuccinic acid, which is available, inter alia, from Bayer AG under the trade names Iminodisuccinate VP OC 370 (about 30% strength solution) and Baypure CX 100 solid.

Particularly advantageous preparations are also obtained when antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously comprise one or more antioxidants. Favourable, but nevertheless optional, antioxidants which may be used are all antioxidants customary or suitable for cosmetic and/or dermatological applications.

For the purposes of the present invention, water-soluble antioxidants may be used particularly advantageously, such as, for example, vitamins, e.g. ascorbic acid and derivatives thereof.

Preferred antioxidants are also vitamin E and derivatives thereof, and vitamin A and derivatives thereof.

The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight of the preparation.

If vitamin E and/or derivatives thereof are the antioxidant or the antioxidants, it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation.

If vitamin A or vitamin A derivatives, or carotenes or derivatives thereof are the antioxidant or the antioxidants, it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation.

It is particularly advantageous when the cosmetic preparations according to the present invention comprise cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin against oxidative stress.

Further advantageous active ingredients for the purposes of the present invention are natural active ingredients and/or derivatives thereof, such as, for example, α-lipoic acid, phytoene, D-biotin, coenzyme Q10, α-glucosylrutin, carnitine, carnosine, natural and/or synthetic isoflavonoids, creatine, taurine and/or β-alanine, and 8-hexadecene-1,16-dicarboxylic acid (dioic acid, CAS number 20701-68-2; provisional INCI name Octadecenedioic acid).

Formulations according to the invention which comprise, for example, known antiwrinkle active ingredients, such as flavone glycosides (in particular α-glycosylrutin), coenzyme Q10, vitamin E and/or derivatives and the like are particularly advantageously suitable for the prophylaxis and treatment of cosmetic or dermatological changes in the skin, as arise, for example, during the skin ageing (such as, for example, dryness, roughness and formation of dryness wrinkles, itching, reduced refatting (e.g. after washing), visible vascular dilations (telangiectases, cuperosis), flaccidity and formation of wrinkles and lines, local hyperpigmentation, hypopigmentation and incorrect pigmentation (e.g. age spots), increased susceptibility to mechanical stress (e.g. cracking) and the like). In addition, they are advantageously suitable to counter the appearance of dry or rough skin.

The water phase of the preparations according to the invention can advantageously comprise customary cosmetic auxiliaries, such as, for example, alcohols, in particular those of low carbon number, preferably ethanol and/or isopropanol, diols or polyols of low carbon number, and ethers thereof, preferably propylene glycol, glycerol, butylene glycol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, polymers, foam stabilizers, electrolytes, and in particular one or more thickeners, which may advantageously be chosen from the group consisting of silicon dioxide, aluminium silicates or polysaccharides or derivatives thereof, e.g. hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols [from Goodrich], for example Carbopol grades 980, 981, 1382, 2984, 5984, ETD 2020, ETD 2050, Ultrez 10, in each case individually or in combination.

In addition, the preparations according to the invention can advantageously also comprise self-tanning substances, such as, for example, dihydroxyacetone and/or melanin derivatives in concentrations of from 1% by weight to 8% by weight, based on the total weight of the preparation.

In addition, the preparations according to the invention can advantageously also comprise repellents for protection against flies, ticks and spiders and the like. For example, N,N-diethyl-3-methylbenzamide (trade name: Meta-delphene, “DEET”), dimethyl phthalate (trade name: Palatinol M, DMP) and in particular ethyl 3-(N-n-butyl-N-acetylamino)propionate (available under the trade name Insekt Repellent® 3535 from Merck) are advantageous. The repellents can either be used individually or in combination.

Moisturizers is the term used to refer to substances or mixtures of substances which impart to cosmetic or dermatological preparations the property, following application or distribution on the surface of the skin, of reducing moisture release by the horny layer (also called trans-epidermal water loss (TEWL)) and/or of positively influencing hydration of the horny layer.

Advantageous moisturizers for the purposes of the present invention are, for example, glycerol, lactic acid and/or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccharide gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidonecarboxylic acid and urea. In addition, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and/or water-swellable and/or water-gelable polysaccharides. Hyaluronic acid, chitosan and/or a fucose-rich polysaccharide, which is filed in the Chemical Abstracts under the registry number 178463-23-5 and which is available, for example, under the name Fucogel® 1000 by SOLABIA S.A., for example, are particularly advantageous. Moisturizers can advantageously also be used as anti-wrinkle active ingredients for the prophylaxis and treatment of cosmetic or dermatological changes in the skin, as arise, for example, during skin ageing.

The cosmetic or dermatological preparations according to the invention can also advantageously, but not necessarily, comprise fillers, which, for example, further improve the sensory and cosmetic properties of the formulations and, for example, bring about or enhance a velvety or silky feel on the skin. Advantageous fillers for the purposes of the present invention are starch and starch derivatives (such as, for example, tapioca starch, distarch phosphate, aluminium or sodium starch octenylsuccinate and the like), pigments which have neither a primarily UV filter effect nor a colouring effect (such as, for example, boron nitride etc.) and/or Aerosils® (CAS No. 7631-86-9).

The oil phase of the formulations according to the invention is advantageously chosen from the group of polar oils, for example from the group of lecithins and of fatty acid triglycerides, namely the triglycerol esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids with a chain length of from 8 to 24, in particular 12 to 18, carbon atoms. The fatty acid triglycerides can, for example, be chosen advantageously from the group of synthetic, semisynthetic and natural oils, such as, for example, cocoglyceride, olive oil, sunflower oil, soya oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheatgerm oil, grapeseed oil, thistle oil, evening primrose oil, macadamia nut oil and the like.

Also advantageous according to the invention are, for example, natural waxes of animal and vegetable origin, such as, for example, beeswax and other insect waxes, and berry wax, sheabutter and/or lanolin (woolwax). It is also advantageous to choose wax components from the group of glycerides, in particular from the group of triglycerides. For the purposes of the present invention, C₁₈₋₃₆ triglyceride, which is available under the trade name Syncrowax HGLC from Croda GmbH, is particularly advantageous.

Further advantageous polar oil components for the purposes of the present invention may also be chosen from the group of esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids of chain length from 3 to 30 carbon atoms and saturated and/or unsaturated, branched and/or unbranched alcohols of chain length from 3 to 30 carbon atoms, and from the group of esters of aromatic carboxylic acids and saturated and/or unsaturated, branched and/or unbranched alcohols of chain length from 3 to 30 carbon atoms. Such ester oils can then advantageously be chosen from the group consisting of octyl palmitate, octyl cocoate, octyl isostearate, octyldodecyl myristate, octyldodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearyl heptanoate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, tridecyl stearate, tridecyl trimellitate, and synthetic, semisynthetic and natural mixtures of such esters, such as, for example, jojoba oil.

In addition, the oil phase can advantageously be chosen from the group of dialkyl ethers and dialkyl carbonates, advantageous examples being dicaprylyl ether (Cetiol OE) and/or dicaprylyl carbonate, for example that available under the trade name Cetiol CC from Cognis.

It is also preferred to choose the oil component or oil components from the group consisting of isoeicosane, neopentyl glycol diheptanoate, propylene glycol dicaprylate/dicaprate, caprylic/capric/diglyceryl succinate, butylene glycol dicaprylate/dicaprate, C₁₂₋₁₃-alkyl lactate, di-C₁₂₋₁₃-alkyl tartrate, triisostearin, dipentaerythritol hexacaprylate/hexacaprate, propylene glycol monoisostearate, tricaprylin, dimethyl isosorbide. It is particularly advantageous if the oil phase of the formulations according to the invention has a content of C₁₂₋₁₅-alkyl benzoate or consists entirely of this.

Advantageous oil components are also, for example, butyloctyl salicylate (for example that available under the trade name Hallbrite BHB from CP Hall), hexadecyl benzoate and butyloctyl benzoate and mixtures thereof (Hallstar AB) and/or diethylhexyl naphthalate (Hallbrite TQ or Corapan TQ from H&R).

Any mixtures of such oil and wax components can also be used advantageously for the purposes of the present invention.

In addition, the oil phase can likewise advantageously also comprise nonpolar oils, for example those which are chosen from the group of branched and unbranched hydrocarbons and hydrocarbon waxes, in particular mineral oil, vaseline (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohexadecane. Among the polyolefins, polydecenes are the preferred substances.

The oil phase can also advantageously have a content of cyclic or linear silicone oils, or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components apart from the silicone oil or the silicone oils.

Silicone oils are high molecular weight synthetic polymeric compounds in which silicon atoms are joined via oxygen atoms in a chain-like and/or reticular manner and the remaining valencies of the silicon are saturated by hydrocarbon radicals (in most cases methyl groups, more rarely ethyl, propyl, phenyl groups, etc.). Systematically, the silicone oils are referred to as polyorganosiloxanes. The methyl-substituted polyorganosiloxanes, which represent the most important compounds of this group in terms of amount and are characterized by the following structural formula

are also referred to as polydimethylsiloxane or Dimethicone (INCI). Dimethicones exist in various chain lengths and with various molecular weights.

Particularly advantageous polyorganosiloxanes for the purposes of the present invention are, for example, dimethylpolysiloxanes [poly(dimethylsiloxane)], which are available, for example, under the trade names Abil 10 to 10 000 from Th. Goldschmidt. Also advantageous are phenylmethylpolysiloxanes (INCI: Phenyl Dimethicone, Phenyl Trimethicone), cyclic silicones (octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane), which are also referred to as Cyclomethicone in accordance with INCI, amino-modified silicones (INCI: Amodimethicones) and silicone waxes, e.g. polysiloxane-polyalkylene copolymers (INCI: Stearyl Dimethicones and Cetyl Dimethicones) and dialkoxydimethylpolysiloxanes (Stearoxy Dimethicones and Behenoxy Stearyl Dimethicones), which are available as various Abil wax grades from Th. Goldschmidt. However, other silicone oils can also be used advantageously for the purposes of the present invention, for example cetyidimethicone, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly(methylphenylsiloxane).

The preparations according to the invention can also advantageously comprise one or more substances from the following group of siloxane elastomers, for example in order to increase the water resistance and/or the light protection factor of the products:

-   (a) siloxane elastomers which contain the units R₂SiO and RSiO_(1.5)     and/or R₃SiO_(0.5) and/or SiO₂,     -   where the individual radicals R, in each case independently of         one another, are hydrogen, C₁₋₂₄-alkyl (such as, for example,         methyl, ethyl, propyl) or aryl (such as, for example, phenyl or         tolyl), alkenyl (such as, for example, vinyl), and the weight         ratio of the units R₂SiO to RSiO_(1.5) is chosen from the range         from 1:1 to 30:1; -   (b) siloxane elastomers which are insoluble and swellable in     silicone oil and which are obtainable by the addition reaction of an     organopolysiloxane (1) which contains silicon-bonded hydrogen with     an organopolysiloxane (2) which contains unsaturated aliphatic     groups,     -   where the quantitative amounts used are chosen such that the         amount of hydrogen in the organopolysiloxane (1) or in the         unsaturated aliphatic groups of the organopolysiloxane (2)     -   is in the range from 1 to 20 mol % when the organopolysiloxane         is noncyclic and     -   is in the range from 1 to 50 mol % when the organopolysiloxane         is cyclic.

For the purposes of the present invention, the siloxane elastomer or elastomers are advantageously present in the form of spherical powders or in the form of gels.

Siloxane elastomers present in the form of spherical powders which are advantageous according to the invention are those with the INCI name DimethiconeNinyl Dimethicone Crosspolymer, for example that available from DOW CORNING under the trade names DOW CORNING 9506 Powder.

It is particularly preferred when the siloxane elastomer is used in combination with oils from hydrocarbons of animal and/or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof.

It is very particularly preferred when the siloxane elastomer is used in combination with unbranched silicone oils which are liquid or pasty at room temperature or cyclic silicone oils or mixtures thereof. Organopolysiloxane elastomers with the INCI name Dimethicone/Polysilicone-11, very particularly the Gransil grades obtainable from Grant Industries Inc. GCM, GCM-5, DMG-6, CSE gel, PM-gel, LTX, ININ gel, AM-18 gel and/or DMCM-5 are particularly advantageous.

It is very extremely preferred when the siloxane elastomer is used in the form of a gel of siloxane elastomer and a lipid phase where the content of the siloxane elastomer in the gel is 1 to 80% by weight, preferably 0.1 to 60% by weight, in each case based on the total weight of the gel.

It is advantageous for the purposes of the present invention to choose the total amount of the siloxane elastomers (active content) from the range from 0.01 to 10% by weight, advantageously from 0.1 to 5% by weight, in each case based on the total weight of the formulation.

The cosmetic and dermatological preparations according to the invention can comprise dyes and/or colour pigments, particularly when they are in the form of decorative cosmetics. The dyes and colour pigments can be chosen from the corresponding positive list in the Cosmetics Directive or the EC list of cosmetic colorants. In most cases, they are identical to dyes approved for foods. Advantageous colour pigments are, for example, titanium dioxide, mica, iron oxides (e.g. Fe₂O₃, Fe₃O₄, FeO(OH)) and/or tin oxide. Advantageous dyes are, for example, carmine, Prussian blue, chromium oxide green, ultramarine blue and/or manganese violet. It is particularly advantageous to choose the dyes and/or the colour pigments from the Rowe Colour Index, 3^(rd) Edition, Society of Dyers and Colourists, Bradford, England, 1971.

If the formulations according to the invention are in the form of products which are used on the face, it is favourable to choose one or more substances from the following group as the dye: 2,4-dihydroxyazobenzene, 1-(2′-chloro-4′-nitro-1′-phenylazo)-2-hydroxynaphthalene, Ceres red, 2-(sulpho-1-naphthylazo)-1-naphthol-4-sulphonic acid, calcium salt of 2-hydroxy-1,2′-azonaphthalene-1′-sulphonic acid, calcium and barium salts of 1-(2-sulpho-4-methyl-1-phenylazo)-2-naphthylcarboxylic acid, calcium salt of 1-(2-sulpho-1-naphthylazo)-2-hydroxynaphthalene-3-carboxylic acid, aluminium salt of 1-(4-sulpho-1-phenylazo)-2-naphthol-6-sulphonic acid, aluminium salt of 1-(4-sulpho-1-naphthylazo)-2-naphthol-3,6-disulphonic acid, 1-(4-sulpho-1-naphthylazo)-2-naphthol-6,8-disulphonic acid, aluminium salt of 4-(4-sulpho-1-phenylazo)-1-(4-sulphophenyl)-5-hydroxypyrazolone-3-carboxylic acid, aluminium and zirconium salts of 4,5-dibromofluorescein, aluminium and zirconium salts of 2,4,5,7-tetrabromofluorescein, 3′,4′,5′,6′-tetrachloro-2,4,5,7-tetrabromofluorescein and its aluminium salt, aluminium salt of 2,4,5,7-tetraiodofluorescein, aluminium salt of quinophthalonedisulphonic acid, aluminium salt of indigodisulphonic acid, red and black iron oxide (CIN: 77 491 (red) and 77 499 (black)), iron oxide hydrate (CIN: 77 492), manganese ammonium diphosphate and titanium dioxide.

Also advantageous are oil-soluble natural dyes, such as, for example, paprika extracts, β-carotene or cochineal.

Also advantageous for the purposes of the present invention are formulations with a content of pearlescent pigments. Preference is given in particular to the types of pearlescent pigments listed below:

-   1. Natural pearlescent pigments, such as, for example,     -   “pearlessence” (guanine/hypoxanthin mixed crystals from fish         scales) and     -   “mother-of-pearl” (ground mussel shells) -   2. Monocrystalline pearlescent pigments, such as, for example,     bismuth oxychloride (BiOCl) -   3. Layer-substrate pigments: e.g. mica/metal oxide

Bases for pearlescent pigments are, for example, pulverulent pigments or castor oil dispersions of bismuth oxychloride and/or titanium dioxide, and bismuth oxychloride and/or titanium dioxide on mica. The lustre pigment listed under CIN 77163, for example, is particularly advantageous.

Also advantageous are, for example, the following types of pearlescent pigments based on mica/metal oxide: Coating/ Group layer thickness Colour Silver-white pearlescent TiO₂: 40-60 nm Silver pigments Interference pigments TiO₂: 60-80 nm Yellow TiO₂: 80-100 nm Red TiO₂: 100-140 nm Blue TiO₂: 120-160 nm Green Colour lustre pigments Fe₂O₃ Bronze Fe₂O₃ Copper Fe₂O₃ Red Fe₂O₃ Red-violet Fe₂O₃ Red-green Fe₂O₃ Black Combination pigments TiO₂/Fe₂O₃ Gold shades TiO₂/Cr₂O₃ Green TiO₂/Prussian blue Deep blue TiO₂/carmine Red

Particular preference is given, for example, to the pearlescent pigments obtainable from Merck under the trade names Timiron, Colourona or Dichrona.

The list of given pearlescent pigments is not of course intended to be limiting. Pearlescent pigments which are advantageous for the purposes of the present invention are obtainable by numerous methods known per se. For example, other substrates apart from mica can be coated with further metal oxides, such as, for example, silica and the like. SiO₂ particles coated with, for example, TiO₂ and Fe₂O₃ (“ronaspheres”), which are sold by Merck and are particularly suitable for the optical reduction of fine lines, are advantageous.

It can, moreover, be advantageous to dispense completely with a substrate such as mica. Particular preference is given to iron pearlescent pigments prepared without the use of mica. Such pigments are obtainable, for example, under the trade name Sicopearl Kupfer 1000 from BASF.

In addition, also particularly advantageous are effect pigments which are obtainable under the trade name Metasomes Standard/Glitter in various colours (yellow, red, green, blue) from Flora Tech. The glitter particles are present here in mixtures with various auxiliaries and dyes (such as, for example, the dyes with the Colour Index (CI) numbers 19140, 77007, 77289, 77491).

The dyes and pigments may be present either individually or in a mixture, and can be mutually coated with one another, different coating thicknesses generally giving rise to different colour effects. The total amount of dyes and colour-imparting pigments is advantageously chosen from the range from, for example, 0.1% by weight to 30% by weight, preferably from 0.5 to 15% by weight, in particular from 1.0 to 10% by weight, in each case based on the total weight of the preparations.

For the purposes of the present invention, it is also advantageous to provide cosmetic and dermatological preparations whose main purpose is not protection against sunlight, but which nevertheless have a content of further UV protection substances. Thus, for example, UV-A and/or UV-B filter substances are usually incorporated into daycreams or make-up products. UV protection substances, like antioxidants and, if desired, preservatives, also constitute effective protection of the preparations themselves against spoilage. Also favourable are cosmetic and dermatological preparations in the form of a sunscreen.

Accordingly, for the purposes of the present invention, the preparations can preferably comprise further UV-A, UV-B and/or broadband filter substances. The formulations can, but do not necessarily, optionally comprise one or more organic and/or inorganic pigments as UV filter substances, which may be present in the water phase and/or the oil phase.

In addition, the preparations according to the invention can also advantageously be in the form of so-called oil-free cosmetic or dermatological emulsions, which comprise a water phase and at least one UV filter substance which is liquid at room temperature as a further phase.

For the purposes of the present invention, particularly advantageous UV filter substances which are liquid at room temperature are homomenthyl salicylate (INCI: Homosalate), 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: Octocrylene), 2-ethylhexyl 2-hydroxybenzoate (2-ethylhexyl salicylate, octyl salicylate, INCI: Ethylhexyl Salicylate), 3-(4-(2,2-bisethoxycarbonylvinyl)phenoxy)propenyl)methoxysiloxane/dimethylsiloxane copolymer, which is available, for example, under the trade name Parsol® SLX from Hoffmann La Roche.

Preferred further inorganic pigments are metal oxides and/or other metal compounds which are insoluble or sparingly soluble in water, in particular oxides of zinc (ZnO), iron (e.g. Fe₂O₃), zirconium (ZrO₂), silicon (SiO₂), manganese (e.g. MnO), aluminium (Al₂O₃), cerium (e.g. Ce₂O₃), mixed oxides of the corresponding metals, and mixtures of such oxides, and also the sulphate of barium (BaSO₄).

According to the invention, the pigments may advantageously be surface-treated (“coated”), the intention being to form or retain, for example, a hydrophilic, amphiphilic or hydrophobic character. This surface treatment can consist in providing the pigments with a thin hydrophilic and/or hydrophobic inorganic and/or organic coat by methods known per se.

Inorganic surface coatings for the purposes of the present invention may consist of aluminium oxide (Al₂O₃), aluminium hydroxide Al(OH)₃, or aluminium oxide hydrate (also: alumina, CAS No.: 1333-84-2), sodium hexametaphosphate (NaPO₃)₆, sodium metaphosphate (NaPO₃)_(n), silicon dioxide (SiO₂) (also: silica, CAS No.: 7631-86-9), or iron oxide (Fe₂O₃). These inorganic surface coatings may be present on their own, in combination and/or in combination with organic coating materials.

Organic surface coatings for the purposes of the present invention may consist of vegetable or animal aluminium stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: Dimethicone), methylpolysiloxane (Methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of from 200 to 350 dimethylsiloxane units and silica gel) or alginic acid. These organic surface coatings may be present on their own, in combination and/or in combination with inorganic coating materials.

Zinc oxide particles and predispersions of zinc oxide particles which are suitable according to the invention are obtainable under the following trade names from the companies listed: Trade name Coating Manufacturer Z-Cote HP1 2% Dimethicone BASF Z-Cote / BASF ZnO NDM 5% Dimethicone H&R MZ-303S 3% Methicone Tayca Corporation MZ-505S 5% Methicone Tayca Corporation

Further advantageous pigments are latex particles. Latex particles advantageous according to the invention are those described in the following specifications: U.S. Pat. No. 5,663,213 and EP 0 761 201. Particularly advantageous latex particles are those which are formed from water and styrene/acrylate copolymers and are available, for example, under the trade name “Alliance SunSphere” from Rohm & Haas.

Advantageous further UV filter substances for the purposes of the present invention are sulphonated, water-soluble UV filters, such as, for example:

-   Phenylene-1,4-bis(2-benzimidazyl)-3,3′-5,5′-tetrasulphonic acid and     its salts, particularly the corresponding sodium, potassium or     triethanolammonium salts, in particular the     phenylene-1,4-bis(2-benzimidazyl)-3,3′-5,5′-tetrasulphonic acid     bis-sodium salt with the INCI name Disodium Phenyl Dibenzimidazole     Tetrasulphonate (CAS No.: 180898-37-7), which is available, for     example, under the trade name Neo Heliopan AP from Haarmann &     Reimer; -   Salts of 2-phenylbenzimidazole-5-sulphonic acid, such as its sodium,     potassium or its triethanolammonium salt, and the sulphonic acid     itself with the INCI name Phenylbenzimidazole Sulphonic Acid (CAS     No. 27503-81-7), which is available, for example, under the trade     name Eusolex 232 from Merck, or under Neo Heliopan Hydro from     Haarmann & Reimer; -   1,4-di(2-oxo-10-sulpho-3-bornylidenemethyl)benzene (also:     3,3′-(1,4-phenylenedimethylene)bis(7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-ylmethanesulphonic     acid) and salts thereof (particularly the corresponding 10-sulphato     compounds, in particular the corresponding sodium, potassium or     triethanolammonium salt), which is also referred to as     benzene-1,4-di(2-oxo-3-bornylidenemethyl-10-sulphonic acid).     Benzene-1,4-di(2-oxo-3-bornylidenemethyl-10-sulphonic acid) has the     INCI name Terephthalidene Dicamphor Sulphonic Acid (CAS No.:     90457-82-2) and is available, for example, under the trade name     Mexoryl SX from Chimex; -   Sulphonic acid derivatives of 3-benzylidenecamphor, such as, for     example, 4-(2-oxo-3-bornylidenemethyl)benzenesulphonic acid,     2-methyl-5-(2-oxo-3-bornylidenemethyl)sulphonic acid and salts     thereof.

Advantageous UV filter substances for the purposes of the present invention are also benzoxazole derivatives which are characterized by the following structural formula

in which R¹, R² and R³, independently of one another, are chosen from the group of branched or unbranched, saturated or unsaturated alkyl radicals having 1 to 10 carbon atoms. According to the invention, it is particularly advantageous to choose the radicals R¹ and R² to be equal, in particular from the group of branched alkyl radicals having 3 to 5 carbon atoms. For the purposes of the present invention, it is also particularly advantageous if R³ is an unbranched or branched alkyl radical having 8 carbon atoms, in particular the 2-ethylhexyl radical.

A benzoxazole derivative which is particularly preferred according to the invention is 2,4-bis[5-1(dimethylpropyl)benzoxazol-2-yl(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine with the CAS No. 288254-16-0, which is characterized by the structural formula

and is available from 3V Sigma under the trade name Uvasorb® K2A.

The benzoxazole derivative or derivatives are advantageously present in dissolved form in the cosmetic preparations according to the invention. It may in some instances, however, also be advantageous if the benzoxazole derivative or derivatives are present in pigmentary, i.e. undissolved, form—for example in particle sizes of from 10 nm to 300 nm.

Advantageous UV filter substances for the purposes of the present invention are also so-called hydroxybenzophenones. Hydroxybenzophenones are characterized by the following structural formula:

in which

-   R¹ and R², independently of one another, are hydrogen, C₁-C₂₀-alkyl,     C₃-C₁₀-cycloalkyl or C₃-C₁₀-cycloalkenyl, where the substituents R¹     and R², together with the nitrogen atom to which they are bonded,     can form a 5-membered or 6-membered ring and -   R³ is a C₁-C₂₀-alkyl radical.

A particularly advantageous hydroxybenzophenone for the purposes of the present invention is hexyl 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoate (also: Aminobenzophenone), which is characterized by the following structure:

and is available under Uvinul A Plus from BASF.

Advantageous UV filter substances for the purposes of the present invention are also so-called broadband filters, i.e. filter substances which absorb both UV-A and also UV-B radiation.

Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as, for example,

-   2,4-Bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine     (INCI: BisEthylhexyloxyphenol Methoxyphenyl Triazine), which is     available under the trade name Tinosorb® S from CIBA-Chemikalien     GmbH; -   Dioctylbutylamidotriazone (INCI: Diethylhexylbutamidotriazone),     which is available under the trade name UVASORB HEB from Sigma 3V; -   Tris(2-ethylhexyl)4,4′,4″-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoate,     also:     2,4,6-tris[anilino(p-carbo-2′-ethyl-1′-hexyloxy)]-1,3,5-triazine     (INCI: Ethylhexyl Triazone), which is sold by BASF     Aktiengesellschaft under the trade name UVINUL® T 150; -   2-[4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol     (CAS No.: 2725-22-6).

An advantageous broadband filter for the purposes of the present invention is also 2,2′-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol), (INCI: Methylene Bis-Benztriazolyl Tetramethylbutylphenol), which is available, for example, under the trade name Tinosorb® M from CIBA-Chemikalien GmbH.

For the purposes of the present invention, an advantageous broadband filter is also 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]phenol (CAS No.: 155633-54-8) with the INCI name Drometrizole Trisiloxane.

The further UV filter substances may be oil-soluble or water-soluble. Advantageous oil-soluble filter substances are, for example:

-   3-benzylidenecamphor derivatives, preferably     3-(4-methylbenzylidene)camphor, 3-benzylidenecamphor; -   4-aminobenzoic acid derivatives, preferably 2-ethylhexyl     4-(dimethylamino)benzoate, amyl 4-(dimethylamino)benzoate; -   2,4,6-trianilino(p-carbo-2′-ethyl-1′-hexyloxy)-1,3,5-triazine; -   esters of benzalmalonic acid, preferably di(2-ethylhexyl)     4-methoxybenzalmalonate; -   derivatives of benzophenone, preferably     2-hydroxy-4-methoxybenzophenone,     2-hydroxy-4-methoxy-4′-methylbenzophenone,     2,2′-dihydroxy-4-methoxybenzophenone and -   UV filters bonded to polymers.

Advantageous water-soluble filter substances are, for example:

Sulphonic acid derivatives of 3-benzylidenecamphor, such as, for example, 4-(2-oxo-3-bornylidenemethyl)benzenesulphonic acid, 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulphonic acid and salts thereof.

The list of given UV filters which can be used for the purposes of the present invention is not of course intended to be limiting.

The preparations according to the invention advantageously comprise the substances which absorb UV radiation in the UV-A and/or UV-B region in a total amount of, for example, from 2.0% by weight to 40% by weight, preferably from 3.0 to 35% by weight, in particular 5.0 to 30% by weight, in each case based on the total weight of the preparations, in order to provide cosmetic preparations which protect the hair and/or the skin from the entire range of ultraviolet radiation.

The examples below are intended to illustrate the present invention without limiting it. The numerical values in the examples are percentages by weight, based on the total weight of the particular preparations.

EXAMPLES

W/O emulsions 1 2 3 4 5 PEG-30 dipolyhydroxystearate 2.00 4.00 1.00 2.00 1.00 Cetyldimethicone copolyol 4.00 2.50 3.00 Polyglyceryl-2 dipolyhydroxystearate 3.00 1.00 Isostearyl diglyceryl succinate 0.75 0.30 Lauryl methicone copolyol 2.00 Polysorbate-65 2.00 1.50 PEG-100 stearate 1.20 0.70 Cetearyl sulphate 0.25 1.00 Dimethicone 4.00 5.00 2.00 Cyclomethicone 10.00 5.00 5.00 3.00 UVASorb ® K2A 0.50 Uvinul ® A Plus 2.00 4.00 Bisethylhexyloxyphenol methoxyphenyl- 1.00 0.50 triazine Drometrizole trisiloxane 1.00 Phenylbenzimidazolesulphonic acid 0.50 4-Methylbenzylidenecamphor 4.00 Methylenebisbenzotriazolyltetramethyl- 3.00 butylphenol Ethylhexyl methoxycinnamate 3.00 5.00 2.00 1.00 10.00 Diethylhexylbutamidotriazone 1.00 6.50 Ethylhexyltriazone 3.00 4.00 Ethylhexyl salicylate 5.00 3.50 Octocrylene 5.00 2.00 Butylmethoxydibenzoylmethane 3.00 2.00 1.50 3.00 4.00 Titanium dioxide T805 5.00 4.00 2.00 6.00 6.00 Zinc oxide Z-Cote 2.00 1.00 Dicaprylyl carbonate 5.00 15.00 4.00 Isopropyl stearate 5.00 5.00 Butylene glycol dicaprylate/dicaprate 5.00 3.00 Dihexyl carbonate 5.00 C12-15 alkyl benzoate 7.00 10.00 Mineral oil 5.00 6.00 Coconut fatty acid glyceride 2.00 5.00 PVP hexadecene copolymer 0.75 0.40 Glycerol 5.00 12.50 5.00 15.50 Sorbitol 5.00 10.00 α-Glucosylrutin 0.15 EDTA 0.15 0.03 0.15 Glycine soya 0.75 1.50 Magnesium sulphate 0.75 1.00 0.45 1.00 DMDM hydantoin 0.05 0.10 Phenoxyethanol 1.00 0.75 0.50 1.00 Alcohol 2.00 5.00 1.00 NaOH 45% 0.40 Dye, oil-soluble 0.02 Perfume 0.30 0.45 0.35 0.15 Water ad 100 ad 100 ad 100 ad 100 ad 100 6 7 8 9 10 11 Cetyldimethicone copolyol 1.00 PEG-30 4.00 5.00 3.00 5.00 3.00 3.50 dipolyhydroxystearate Bisethylhexyloxyphenol 3.00 1.50 methoxyphenyltriazine Butylmethoxydibenzoyl- 2.00 3.00 4.00 1.50 1.50 4.00 methane UVASorb ® K2A 2.00 Uvinul ® A Plus 1.00 3.00 Phenylbenzimidazole- 2.00 sulphonic acid Neo Heliopan AP 1.00 Ethylhexyl methoxycinnamate 6.00 8.00 1.00 2.00 5.00 4.00 Diethylhexylbutamidotriazone 3.00 1.00 2.00 1.00 3.00 Ethylhexyltriazone 2.00 4.00 Octocrylene 2.00 2.00 2.50 Drometrizole trisiloxane 1.00 Titanium dioxide Uvinul ® TiO₂ 2.50 6.00 3.50 4.00 Titanium dioxide MT-100 TV 2.00 Eusolex T2000 2.00 Zinc oxide Z-Cote ® HP1 3.00 Mineral oil 5.00 5.00 8.00 Coconut fatty acid glyceride 4.00 6.50 5.00 C12-15 alkyl benzoate 5.00 8.00 9.00 Dicaprylyl ether 10.00 5.00 2.00 7.00 Butylene glycol 3.00 9.00 7.00 8.00 4.00 dicaprylate/dicaprate Cetyl dimethicone 0.50 1.00 0.50 C18-36 fatty acid triglyceride 1.00 0.50 1.0 Cyclomethicone 2.00 3.00 3.00 2.00 Na starch octenyl succinate 0.50 0.50 1.00 PVP eicosene copolymer 0.50 1.50 1.00 Trisodium EDTA 1.00 1.00 0.50 0.35 Ethylhexyloxyglycerol 0.30 0.50 Methylpropanediol 7.50 Glycerol 5.00 7.50 6.00 8.00 7.50 2.50 Butylene glycol 2.50 Glycine soya 1.00 MgSO₄ 1.00 0.50 0.30 0.30 0.50 Lactic acid & sodium salt of 1.00 0.50 lactic acid Vitamin E 0.50 0.50 1.00 1.00 DMDM hydantoin 0.60 0.20 Methylparaben 0.50 0.15 Phenoxyethanol 0.50 0.40 0.50 0.60 1.00 0.60 Dihydroxyacetone 5.50 Alcohol 3.00 2.00 3.00 1.00 Perfume 0.20 0.20 0.20 0.20 Water ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 

1. Light protective cosmetic or dermatological preparation, characterized in that it comprises (a) PEG-30 dipolyhydroxystearate, (b) at least one ester of cinnamic acid, (c) at least one dibenzoylmethane derivative and (d) at least 1.5% by weight of titanium dioxide particles (based on the total weight of the preparation).
 2. Preparation according to claim 1, characterized in that it comprises less than 1.5% by weight, based on the total weight of the preparation, of waxes.
 3. Preparation according to one of the preceding claims, characterized in that it comprises less than 1% by weight, based on the total weight of the preparation, of waxes.
 4. Preparation according to one of the preceding claims, characterized in that it comprises no further emulsifiers.
 5. Preparation according to one of the preceding claims, characterized in that the oil phase fraction is more than 35% by weight (based on the total weight of the preparation).
 6. Preparation according to one of the preceding claims, characterized in that it comprises 2-ethylhexyl 4-methoxycinnamate as cinnamic ester.
 7. Preparation according to one of the preceding claims, characterized in that it comprises 4-(tert-butyl)-4′-methoxydibenzoylmethane as dibenzoylmethane derivative. 